Morgan Stanley’s Allergan Inc AGN Stock Holding History

Morgan Stanley’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,121,170	Closed	-$238M	–	6991
2014 Q4	$238M	Buy	1,121,170 +628,382	+128%	+$125M	0.09%	263
2014 Q3	$87.8M	Sell	492,788 -407,013	-45%	-$67.6M	0.03%	561
2014 Q2	$152M	Sell	899,801 -690,833	-43%	-$108M	0.06%	362
2014 Q1	$197M	Sell	1,590,634 -33,135	-2%	-$4.03M	0.08%	275
2013 Q4	$180M	Sell	1,623,769 -2,449	-0.2%	-$234K	0.08%	289
2013 Q3	$147M	Sell	1,626,218 -358,517	-18%	-$32.2M	0.07%	329
2013 Q2	$167M	Buy	+1,984,735	New	+$206M	0.08%	273

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Morgan Stanley's AGN Position: Q1 2015 in Review

Morgan Stanley sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,121,170 shares — an estimated $238M sold.

Morgan Stanley first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $238M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Morgan Stanley reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Morgan Stanley sold 1,121,170 Allergan Inc shares in Q1 2015, an estimated $238M.
Morgan Stanley first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Morgan Stanley's Allergan Inc position peaked at $238M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Morgan Stanley's 13F filing for Q1 2015, filed 14 May 2015.